Last updated: January 26, 2026
Sponsor: Johannes Trueck
Overall Status: Active - Recruiting
Phase
4
Condition
Allergy (Pediatric)
Allergy
Allergies & Asthma
Treatment
Systemic corticosteroids
Antihistamines
Adrenaline (rescue medication)
Clinical Study ID
NCT07341776
BASEC-2025-00320
SNCTP000006696
HumRes67580
Ages 6-18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- suspected or confirmed IgE-mediated food allergy
Exclusion
Exclusion Criteria:
Non-IgE mediated food allergies
Non-food allergies
Age outside the specified range
Contraindications for an oral food challenge or oral steroid use within one weekbefore the challenge.
Study Design
Total Participants: 160
Treatment Group(s): 3
Primary Treatment: Systemic corticosteroids
Phase: 4
Study Start date:
January 26, 2026
Estimated Completion Date:
December 31, 2026
Connect with a study center
University Children's Hospital Basel
Basel 2661604, Basel 4031
SwitzerlandActive - Recruiting
University Children's Hospital, Zürich
Zurich 2657896, Canton of Zurich 2657895 8008
SwitzerlandActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.